HomeHBP • TSE
add
Helix Biopharma Corp.
Previous close
$0.84
Day range
$0.79 - $0.85
Year range
$0.50 - $1.35
Market cap
35.52M CAD
Avg Volume
16.70K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.26M | 145.89% |
Net income | -5.28M | -145.03% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.26M | -146.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.08M | 33.79% |
Total assets | 1.49M | 44.70% |
Total liabilities | 1.58M | -15.74% |
Total equity | -90.00K | — |
Shares outstanding | 49.02M | — |
Price to book | ∞ | — |
Return on assets | -998.86% | — |
Return on capital | 5,846.67% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Net income | -5.28M | -145.03% |
Cash from operations | -748.00K | 51.40% |
Cash from investing | -2.00K | -150.00% |
Cash from financing | 1.10M | 9.82% |
Net change in cash | 371.00K | 171.07% |
Free cash flow | 264.62K | -9.57% |
About
Founded
1995
Headquarters
Website
Employees
7
